No Data
No Data
Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2025/12 (FY2025)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [Japanese GAAP] (consolidated)
Meiji Holdings, Nippon Ham, Tokyu Fudosan Holdings, Asahi Kasei (9th) (130A-5015)
The above Calendar is merely a plan and may be subject to change due to corporate circumstances. --------------------------------------- May 9 (Friday) <130A> VIS <1375> Yukiguni <1414> Showbond <1429> Japan Aqua <143A> Ishin <1450> TANAKEN <151A> Dai <1721> Comsys
Taiko Pharmaceutical: Extraordinary Report
Taiko Pharmaceutical: Confirmation
Taiko Pharmaceutical: Financial Report - 79th Term (2024/01/01 - 2024/12/31)